New study tracks ZEPOSIA safety in pregnant MS patients
NCT ID NCT05170126
First seen Nov 20, 2025 · Last updated May 15, 2026 · Updated 17 times
Summary
This study follows pregnant women with multiple sclerosis who have taken ZEPOSIA to see how it affects their pregnancy and their baby's health. Researchers will collect information on birth defects, pregnancy complications, and infant development. The goal is to help patients and doctors make informed decisions about using ZEPOSIA during pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Evidera
RECRUITINGBethesda, Maryland, 20814, United States
Contact
-
Evidera INC.
RECRUITINGBethesda, Maryland, 20814, United States
Contact
-
Marienhospital Herne, Klinikum Der Ruhr-Universitaet Bochum
RECRUITINGHerne, 44625, Germany
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.